Results 21 to 30 of about 20,925 (217)

Prevalence of small bowel bacterial overgrowth in patients with functional dyspepsia: a meta-analysis

open access: yesТерапевтический архив, 2020
Aim.Systematization of data on the frequency of detection of the syndrome of bacterial overgrowth in the small intestine (SIBO) in patients with functional dyspepsia (FD).
Yu. A. Kucheryavyy   +2 more
doaj   +1 more source

Association between Gut Dysbiosis and the Occurrence of SIBO, LIBO, SIFO and IMO

open access: yesMicroorganisms, 2023
Gut microbiota is the aggregate of all microorganisms in the human digestive system. There are 1014 CFU/mL of such microorganisms in the human body, including bacteria, viruses, fungi, archaea and protozoa. The Firmicutes and Bacteroidetes bacteria phyla
Michalina Banaszak   +4 more
doaj   +1 more source

PREVALENCE OF SMALL INTESTINE BACTERIAL OVERGROWTH IN PATIENTS WITH GASTROINTESTINAL SYMPTOMS

open access: yesArquivos de Gastroenterologia, 2017
BACKGROUND Small intestine bacterial overgrowth is a heterogeneous syndrome characterized by an increase in the number and/or the presence of atypical microbiota in the small intestine. The symptoms of small intestine bacterial overgrowth are unspecific,
Carolina Piedade MARTINS   +4 more
doaj   +1 more source

Treatment of small intestinal bacterial overgrowth: Conventional antibiotic therapy and alternative therapy - probiotics and low FODMAP diet

open access: yesJournal of Education, Health and Sport, 2023
Introduction and purpose of the study: Small intestinal bacterial overgrowth syndrome (SIBO) is a syndrome characterized by an increased number of bacteria in the small intestine.
Maria Litwiniuk   +9 more
doaj   +1 more source

Bacterial overgrowth syndrome: from problem understanding to treatment

open access: yesМедицинский совет, 2017
The review summarizes recent findings on the syndrome of small intestine bacterial overgrowth (SIBO) which is not a separate disease. The triggers of SIBO and the impact on gastrointestinal physiology are considered.
N. I. Ursova
doaj   +1 more source

Efficacy of Probiotics for Prevention of Small Intestinal Bacterial Overgrowth (SIBO) Recurrence among Patients with Irritable Bowel Syndrome (IBS) [PDF]

open access: yesAfro-Egyptian Journal of Infectious and Endemic Diseases, 2020
Introduction and study aim: IBS is the most common functional disorder of gastrointestinal (GI) tract. It is shown that intestinal microbiota plays an important role in the pathogenesis of Irritable Bowel Syndrome (IBS).
Abdol-Rahim Masjedizadeh   +2 more
doaj   +1 more source

TO THE QUESTION OF DIAGNOSTICS AND PATHOGENETIC THERAPY OF ENTEROPATHY IN PATIENTS WITH CHOLELITHIASIS

open access: yesАрхивъ внутренней медицины, 2016
The aim. Specification the features of violations of the functional characteristics of the small intestine and definition the way of correction in patients with cholelithiasis. Materials and methods. 75 patients with prestone stage of cholelithiasis were
Ya. M. Vakhrushev, A. P. Lukashevich
doaj   +1 more source

THE ETHIOPATOGENESIS AND THE ANALYSIS OF AN ANTIBIOTIC TREATMENT OF A SMALL INTESTINE BACTERIAL OVERGROWTH SYNDROME

open access: yesБюллетень сибирской медицины, 2015
Article is attempt of the critical analysis of modern approaches to treatment of a small intestine bacterial overgrowth syndrome (SIBO). SIBO now is one of the major problems in gastroenterology.
V. L. Martynov, A. Kh. Khairdinov
doaj   +1 more source

The Origins of the Pathology of the Gastrointestinal Tract in Children

open access: yesДетские инфекции (Москва), 2016
Objective: To determine the peculiarities of the intestinal microbiota in infants and its role in the development of gastrointestinal pathology.Clinical and microbiological examination of 60 pairs of «mother-child» in identifying risk factors for ...
L. A. Lityaeva, O. V. Kovalеva
doaj   +1 more source

Microbiome−host proteostasis crosstalk—An emerging perspective on mechanisms and interventions toward healthy longevity

open access: yesFEBS Letters, EarlyView.
Proteostasis and the gut microbiota play a key role in shaping host physiology. Microbiota‐derived metabolites, vitamins, and RNA modulate host proteostasis. Findings from model systems, including C. elegans, indicate microbes can either stabilize or disrupt host proteostasis.
Abhishek Anil Dubey, Maria Ermolaeva
wiley   +1 more source

Home - About - Disclaimer - Privacy